DACH1在舌鳞状细胞癌及舌不典型增生中的表达及意义

doi:10.19439/j.sjos.2017.01.013

上海口腔医学 ›› 2017, Vol. 26 ›› Issue (1): 64-68.doi: 10.19439/j.sjos.2017.01.013

DACH1在舌鳞状细胞癌及舌不典型增生中的表达及意义

张丽^*, 刘芬^*, 项锋钢, 王成勤

青岛大学附属医院病理科,山东青岛 266003

收稿日期:2016-04-08 修回日期:2016-07-10 出版日期:2017-02-25 发布日期:2017-03-20
通讯作者: 项锋钢,E-mail：xiangfenggang@163.com;
作者简介:张丽（1984-）,女,硕士,E-mail：gummymyf@163.com; 刘芬（1990-）,女,硕士,E-mail：wfkerry09@163.com。*并列第一作者
基金资助:
国家自然科学基金（81202142）

Expression and significance of human Dachshund homolog 1 in tongue squamous cell carcinoma and tongue atypical hyperplasia

ZHANG Li, LIU Fen, XIANG Feng-gang, WANG Cheng-qin

Department of Pathology, Affiliated Hospital of Qingdao University. Qingdao 266003, Shandong Province, China

Received:2016-04-08 Revised:2016-07-10 Online:2017-02-25 Published:2017-03-20

摘要/Abstract

摘要： 目的探讨细胞命运决定因子（Dachshund homolog 1,DACH1)蛋白在舌鳞状细胞癌发生、发展及预后中的作用。方法应用免疫组织化学方法检测51例舌鳞状细胞癌及其对应癌周正常组织、25例舌不典型增生组织中DACH1的表达。采用SPSS16.0软件包进行统计学处理。结果 51例舌鳞状细胞癌中,36例（70.6%）DACH1表达显著低于癌周正常组织（P<0.05）;DACH1低表达与肿瘤分化差、临床分期晚及淋巴结转移相关;DACH1在舌不典型增生中的表达显著低于舌鳞癌组织（P<0.05）。单因素生存分析显示,DACH1高表达的舌癌患者,总体生存率显著高于低表达组（P<0.05）。结论 DACH1表达降低可能与舌鳞状细胞癌的发生、发展及不良预后有关,可能有助于舌癌前病变的辅助判断,并为肿瘤治疗提供潜在靶点。

关键词: 细胞命运决定因子, 鳞状细胞癌, 不典型增生

Abstract: PURPOSE: To investigate the expression and role of human Dachshund homolog1(DACH1)in the development and prognosis of tongue squamous cell carcinoma(TSCC). METHODS: The expression of DACH1 was detected immunohistochemistrically in 51 samples of paraffin-embedded TSCC, paired adjacent tissues and 25 samples of atypical hyperplasia tissues of the tongue. Statistical analysis was performed using SPSS 16.0 software package. RESULTS: The results showed that 36 out of 51 TSCCs (70.6%) expressed lower levels of DACH1 compared with the paired adjacent tissues. Moreover, there was significant differences in expression of DACH1 between TSCC and paired adjacent tissues (P<0.05), and lower expression was associated with poor differentiation of tumors, advanced clinical stage and lymph node metastasis(P<0.05).In addition, the expression level of DACH1 in atypical hyperplasia tissues of tongue was also significantly lower than in tumors(P<0.05). Univariate survival analysis showed that the overall survival rate of patients with high expression of DACH1 was significantly higher than those with low expression of DACH1 (P<0.05). CONCLUSIONS: The decreased expression of DACH1 may be related to occurrence, development and poor prognosis of TSCC. It may contribute to making diagnosis for precancerous lesions in the tongue, and provide a potential effective therapeutic target for TSCC.

Key words: Dachshund homolog1, Squamous cell carcinoma, Atypical hyperplasia

中图分类号:

R365

张丽, 刘芬, 项锋钢, 王成勤. DACH1在舌鳞状细胞癌及舌不典型增生中的表达及意义[J]. 上海口腔医学, 2017, 26(1): 64-68.

ZHANG Li, LIU Fen, XIANG Feng-gang, WANG Cheng-qin. Expression and significance of human Dachshund homolog 1 in tongue squamous cell carcinoma and tongue atypical hyperplasia[J]. Shanghai Journal of Stomatology, 2017, 26(1): 64-68.

参考文献

[1] Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007 [J]. CA Cancer J Clin, 2007, 57(1): 43-66.
[2] Fakih AR, Rao RS, Borges AM, et al. Elective versus therapeutic neck dissection in early carcinoma of the oral tongue[J]. Am J Surg, 1989, 158(4): 309-313.
[3] Silverman S Jr. Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge [J]. J Am Dent Assoc, 2001, 132 (Suppl): 7S-11S.
[4] Ryott M, Wangsa D, Heselmeyer-Haddad K, et al. EGFR protein overexpression and gene copy number increases in oral tongue squamous cell carcinoma[J]. Eur J Cancer, 2009, 45(9): 1700-1708.
[5] Popov VM, Wu K, Zhou J. The Dachshund gene in development and hormone-responsive tumorigenesis [J]. Trends Endocrinol Metab, 2010, 21(1): 41-49.
[6] Jemc J, Rebay I. Targeting Drosophila eye development [J]. Genome Biol, 2006, 7(7): 226.
[7] Wu K, Li A, Rao M, et al. DACH1 is a cell fate determination factor that inhibits cyclinD1 and breast tumor growth [J]. Mol Cell Biol, 2006, 26(19): 7116-7129.
[8] Chen K, Wu K, Cai S, et al. Dachshund binds p53 to block the growth of lung adenocarcinoma cells[J]. Cancer Res, 2013, 73(11): 3262-3274.
[9] Wu K, Katiyar S, Li A, et al. The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth [J]. Cancer Res, 2009, 69(8): 3347-3355.
[10] Yan W, Wu K, Herman JG, et al. Epigenetic silencing of DACH1, induces the invasion and metastasis of gastric cancer by activating TGF-β signaling [J]. J Cell Mol Med, 2014, 18(12): 2499-2511.
[11] Yan W, Wu K, Herman JG, et al. Epigenetic regulation of DACH1, a novel Wnt signaling component in colorectal cancer[J]. Epigenetics, 2013, 8(12): 1373-1383.
[12] Nan F, Lu QJ, Cheng L, et al. Altered expression of DACH1 and cyclin D1 in endometrial cancer[J]. Cancer Biol Ther, 2009, 8(16): 1534-1539.
[13] Zhu H, Wu K, Yan W, et al. Epigenetic silencing of DACH1 induces loss of transforming growth factor-β1 antiproliferative response in human hepatocellular carcinoma [J]. Hepatology, 2013, 58(6): 2012-2022.
[14] Wu L, Herman JG, Brock MV, et al. Silencing DACH1 promotes esophageal cancer growth by inhibiting TGF-β signaling [J].PLoS One, 2014, 9(4): e95509.
[15] Kawai H, Ishii A, Washiya K, et al. Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer [J].Clin Cancer Res, 2005, 11(14): 5084-5089.
[16] Wang CQ, Xiang FG, Li YJ, et al. Relation between the expression of mitotic centromere-associated kinesin and the progression of squamous cell carcinoma of the tongue[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2013, 117(3): 353-360.
[17] Al-Sarraf M. Treatment of locally advanced head and neck cancer: historical and critical review [J]. Cancer Control, 2002, 9(5): 387-399.
[18] Sano D, Myers JN. Metastasis of squamous cell carcinoma of the oral tongue [J]. Cancer Metastasis Rev, 2007, 26(3-4): 645-662.
[19] Fujii M. Recent multidisciplinary approach with molecular targeted drugs for advanced head and neck cancer [J]. Int J Clin Oncol, 2014, 19(2): 220-229.
[20] Kozmik Z, Cvekl A. Localization of the human homologue of the Drosophila dachshund gene (DACH) to chromosome 13q21 [J]. Genomics, 1999, 59(1): 110-111.
[21] Hammond KL, Hanson IM, Brown AG, et al. Mammalian and Drosophila dachshund genes are related to the Ski proto-oncogene and are expressed in eye and limb [J]. Mech Dev, 1998, 74(1-2): 121-131.
[22] Kim SS, Zhang R, Braunstein SE. Structure of the retinal determination protein Dachshund reveals a DNA binding motif [J]. Structure, 2002, 10(6): 787-795.
[23] Sunde JS, Donninger H, Wu K, et al. Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-β signaling in ovarian cancer [J]. Cancer Res, 2006, 66(17): 8404-8412.
[24] Liang F, Lu Q, Sun S, et al. Increased expression of dachshund homolog 1 in ovarian cancer as a predictor for poor outcome [J]. Int J Gynecol Cancer, 2012, 22(3): 386-393.
[25] Li S, Sun S, Liang F. The significance of DACH1 expression and it's correlation with the expression of ER and PR in endometrium carcinoma [J]. Prog Obstet Gynecol, 2010, 19(6): 406-409.
[26] Popov VM, Zhou J, Shirley LA, et a1. The cell fate determination factor DACH1 is expressed in estrogen receptor-α-positive breast cancer and represses estrogen receptor-αsignaling [J]. Cancer Res, 2009, 69(14): 5752-5760.
[27] Liang F, Lu Q, Sun S, et al. Increased expression of dachshund homolog 1 in ovarian cancer as a predictor for poor outcome [J]. Int J Gynecol Cancer, 2012, 22(3): 386-393.
[28] Zhou J, Liu Y, Zhang W, et a1. Transcription elongation regulator l is a co-integrator of the cell fate determination factor Dachshund homolog 1 [J]. J Biol Chem, 2010, 285(51): 40342-40350.

DACH1在舌鳞状细胞癌及舌不典型增生中的表达及意义

Expression and significance of human Dachshund homolog 1 in tongue squamous cell carcinoma and tongue atypical hyperplasia

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	赵娇, 隋佰延, 刘昕, 阮敏. 口腔鳞状细胞癌免疫相关预后风险模型的构建与验证[J]. 上海口腔医学, 2024, 33(4): 345-353.
[2]	刘文静, 李梦琦, 崔祥, 汪俊兰. circ_0000326靶向miR-567对口腔鳞状细胞癌HSC3细胞增殖、侵袭及迁移的调控效应[J]. 上海口腔医学, 2023, 32(6): 590-596.
[3]	陈兴金, 范然怡, 陶识丞, 薛睿, 文旭涛, 麦华明. 颈淋巴清扫术保留胸锁乳突肌与否对晚期口腔鳞癌预后的影响[J]. 上海口腔医学, 2023, 32(6): 609-614.
[4]	叶婷婷, 陈蔚华, 裴婧, 贾云香, 吴海莹. NEK2与EMT相关分子在口腔鳞状细胞癌中的表达及临床意义[J]. 上海口腔医学, 2023, 32(6): 640-644.
[5]	朱江, 许腾, 宋冬惠, 吴森斌. 口腔鳞状细胞癌组织中RACK1与M2/M1联合检测与预后的相关性分析[J]. 上海口腔医学, 2022, 31(5): 517-522.
[6]	陈娟, 曹若妍, 刘洋, 洪鹏宇, 唐瞻贵. TNFAIP6在口腔疣状癌与口腔鳞状细胞癌中的表达及其与临床病理的关系[J]. 上海口腔医学, 2022, 31(2): 167-172.
[7]	王守鹏, 丁紫雪, 孟箭, 李梦, 李晓东, 袁壮. HIST1H2BH在头颈部鳞状细胞癌中的表达及临床意义[J]. 上海口腔医学, 2021, 30(6): 599-605.
[8]	林阳, 蒋位财, 邱宇, 高炳菊, 李军, 陈鹏, 林李嵩. 基于SEER数据库的颊黏膜鳞状细胞癌的预后列线图构建[J]. 上海口腔医学, 2021, 30(6): 644-648.
[9]	靳能皓, 南欣荣, 闫星泉. BTG1在78例口腔鳞癌中的表达及临床意义[J]. 上海口腔医学, 2021, 30(2): 140-144.
[10]	王科, 彭国光, 谭玉莲, 何善志, 罗翠芬. miR-99a对口腔鳞癌增殖能力的影响[J]. 上海口腔医学, 2021, 30(1): 44-49.
[11]	黄丹妮, 陈文鑫, 熊浩峰, 胡鑫, 毛婷, 苏彤. 口腔鳞状细胞癌患者术后服用二甲双胍对预后的影响[J]. 上海口腔医学, 2021, 30(1): 61-65.
[12]	郑晶, 李天客, 包阳, 张素欣. Spindly和Bub3在口腔鳞状细胞癌中的表达及意义[J]. 上海口腔医学, 2020, 29(5): 528-532.
[13]	齐鑫, 谢敬生, 王梓欣. 腮腺保留式调强放疗对唾液组成、流量及口干的影响[J]. 上海口腔医学, 2020, 29(4): 396-399.
[14]	李羽, 黄文青, 陈林林. LncRNA NEAT1通过miR-339-5p/ITGA3轴调控舌鳞状细胞癌增殖、迁移及侵袭的分子机制[J]. 上海口腔医学, 2020, 29(3): 267-274.
[15]	达雨, 杨震, 夏苗苗, 王梦佳. Ki-67、PI3K、Beclin1在口腔鳞癌组织中的表达及意义[J]. 上海口腔医学, 2020, 29(1): 75-79.